Lab guide
Peptide Purity Testing with HPLC and MS
How reversed-phase HPLC and mass spectrometry are used together to assess research peptide purity and identity, and what a 98% purity figure really means.
By Peptides TT Quality Team · Published · Updated
Two analytical techniques sit behind almost every peptide quality specification: reversed-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS). One measures how much of a sample is the main component; the other confirms what that component is. Understanding how each works, and where each falls short, makes it much easier to interpret a purity figure on a certificate and to judge whether a material is suitable for a given experiment.
Why synthetic peptides contain impurities
Most research peptides are made by solid-phase peptide synthesis, in which amino acids are added one at a time to a growing chain anchored on a resin. Each coupling step is highly efficient but never perfect. Across a sequence of ten, twenty or forty residues, small inefficiencies accumulate. After cleavage from the resin, the crude product is a mixture of the target sequence and closely related by-products. Purification, almost always by preparative RP-HPLC, removes most of these, and analytical testing then measures what remains.
How reversed-phase HPLC works
HPLC separates the components of a mixture as they pass through a packed column under pressure. In the reversed-phase mode used for peptides:
- Stationary phase. The column is packed with silica particles bonded to C18 (octadecyl) chains, creating a hydrophobic surface. Typical analytical columns are 4.6 mm wide and 150–250 mm long, with 3–5 µm particles; wide-pore (300 Å) packings are often used for larger peptides.
- Mobile phase. Solvent A is usually water with 0.1% trifluoroacetic acid (TFA); solvent B is acetonitrile with 0.1% TFA. TFA acts as an ion-pairing agent and sharpens peaks.
- Gradient. A small sample load is placed onto the column and the proportion of acetonitrile is increased steadily, for example from 5% to 65% B over 30 minutes. More hydrophobic species are retained longer and elute later.
- Detection. A UV detector monitors the eluent at 214 or 220 nm, where the peptide bond absorbs strongly. A second channel at 280 nm is sometimes added for sequences containing Trp or Tyr.
Calculating area-% purity
The output is a chromatogram: absorbance plotted against retention time. Each component appears as a peak. Purity by area percentage is calculated as the area of the main peak divided by the sum of all integrated peak areas, multiplied by 100. Because nearly every peptide-like species absorbs at 214 nm, this gives a practical estimate of the relative proportion of the target sequence.
What impurities look like
| Impurity type | Origin | Typical appearance |
|---|---|---|
| Deletion sequences | A residue missed during one coupling step | Small peaks close to the main peak |
| Truncated sequences | Chain growth stopped early (often capped) | Peaks, frequently eluting earlier |
| Oxidised species | Met to sulfoxide, or Trp oxidation | Shoulder or small peak, usually slightly earlier |
| Deamidated species | Asn or Gln converted to Asp or Glu | Peak very close to the main peak |
| Incompletely deprotected species | Side-chain protecting group retained | Later-eluting, more hydrophobic peak |
| Diastereomers | Racemisation of one residue | Very close or co-eluting peak |
Sequences containing Met or Trp, such as Bombesin and Kisspeptin-10, are monitored closely for oxidised species.
How mass spectrometry confirms identity
Mass spectrometry ionises molecules and measures their mass-to-charge ratio (m/z). Two ionisation methods dominate peptide work.
Electrospray ionisation (ESI)
ESI produces ions directly from a liquid stream and readily forms multiply charged ions, written [M+nH]n+. A peptide with a mass of 1,300 Da may appear at m/z of about 1,301 (1+), 651 (2+) and 434 (3+). Software deconvolutes these charge states back to a single neutral mass. ESI couples naturally to HPLC, giving LC-MS.
MALDI
Matrix-assisted laser desorption/ionisation mixes the sample with a light-absorbing matrix and ionises it with a laser pulse. It mostly produces singly charged [M+H]+ ions, making spectra simple to read and well suited to rapid identity checks.
Observed versus theoretical mass
The measured mass is compared with the theoretical molecular weight calculated from the sequence. Agreement within the instrument's tolerance confirms the expected molecule is present. Systematic differences are chemically informative: +16 Da suggests oxidation, +1 Da can indicate deamidation, and a loss equal to one residue mass indicates a deletion. Cyclic peptides such as Cyclo(RGDfK) have a mass 18 Da lower than their linear counterpart, which makes MS an effective check that cyclisation is complete.
Why both techniques are used together
Neither method is sufficient alone.
- HPLC quantifies but does not identify. A single sharp peak at 99% area tells you the sample is homogeneous under those conditions, not that it is the correct sequence.
- MS identifies but does not reliably quantify. Different species ionise with different efficiencies, so peak heights in a mass spectrum do not translate directly into proportions.
Together they answer both questions: the main component is the correct molecule, and it represents a stated share of the detected material. LC-MS goes a step further by assigning a mass to individual chromatographic peaks, which helps identify specific impurities.
Limitations to keep in mind
- Co-elution. Two species with near-identical hydrophobicity can share one peak, inflating the apparent purity.
- Method dependence. Purity depends on column, gradient, wavelength and integration settings. Figures from different methods are not directly comparable.
- Invisible components. Water, TFA and other counter-ions, and inorganic salts do not absorb at 214 nm and are not counted.
- Short sequences. Small peptides such as GRGDS can elute early, close to the solvent front, and may need adjusted conditions.
What "≥98%" means and does not mean
A specification of ≥98% by HPLC means that, under the stated method, the main peak accounts for at least 98% of the integrated UV-absorbing peak area at the detection wavelength.
It does not mean that 98% of the weighed solid is the target peptide. The lyophilized material also contains counter-ions and residual water, so net peptide content is typically lower, often 70–90%. Nor does it guarantee the absence of co-eluting or non-UV-absorbing species. Our guide on how to read a certificate of analysis explains how purity, peptide content and counter-ion figures fit together on the same document.
Summary
RP-HPLC with UV detection measures the relative proportion of the target sequence; mass spectrometry confirms its identity. Used together, they give a reliable picture of a peptide's quality, provided their limits are understood. Explore the receptor-ligand peptides and cell-adhesion peptides in our catalogue, or see how each lot is characterised on our Quality and Testing page.
RESEARCH USE ONLY
For research use only. Not for human or veterinary use. Not a drug, food, supplement or cosmetic. Not intended to diagnose, treat, cure or prevent any disease.
Related topics
- Receptor Ligand Peptides catalogue
- Cell Adhesion Peptides catalogue
- Metabolic Research Peptides catalogue
- GH Secretagogue Research catalogue
- Research Blends catalogue
- Glossary: HPLC (High-Performance Liquid Chromatography)
- Glossary: Mass Spectrometry (MS)
- Glossary: Peptide Purity
- Glossary: Molecular Weight (MW)


